GTSE1 and breast carcinoma: Kaplan-Meier survival analysis of the combined data sets showed that breast cancer patients expressing higher GTSE1 levels in tumors displayed both shorter survival time (p<10−9; Fig. S4B) and a shorter time to distant metastasis (p<10−15; Fig. 6A, Figure S4C).